| DENV/CHIKV (N = 12) | DENV/ZIKV (N = 10) | CHIKV/ZIKV (N = 8) | DENV/CHIKV/ZIKV (N = 3) | p |
---|---|---|---|---|---|
Male % (N) | 50.0 (6) | 0 (0) | 12.5 (1) | 0 (0) | n/a |
Female % (N) | 50.0 (6) | 100 (10) | 87.5 (7) | 100 (3) | n/a |
Age, Years (mean ± SEM) | 23.2 ± 4.6 | 26.5 ± 2.6 | 30.1 ± 2.9 | 30.3 ± 4.2 | 0.492a |
Year (s) | |||||
 0–10 | 33.3 (4) | 0 (0) | 0 (0) | 0 (0) | n/a |
 11–20 | 16.7 (2) | 20.0 (2) | 12.5 (1) | 0 (0) | 0.876c |
 21–30 | 16.7 (2) | 50.0 (5) | 25.0 (2) | 33.3 (1) | 0.475b |
 31–40 | 16.7 (2) | 30.0 (3) | 50.0 (4) | 66.7 (2) | 0.879a |
 41–50 | 8.3 (1) | 0 (0) | 12.5 (1) | 0 (0) | n/a |
 Older than 50 | 8.3 (1) | 0 (0) | 0 (0) | 0 (0) | n/a |
Laboratory diagnosis | |||||
 Prevalence % (95% CI) | 7.6 (3.5–11.8) | 6.4 (2.6–10.2) | 5.1 (1.6–8.5) | 1.9 (0.0–4.1) | 0.205 c |
 Attack rate × 100,000 Inhabitants | 14.9 × 105 | 12.4 × 105 | 9.9 × 105 | 4.9 × 105 | n/a |